Skip to content

Evaluation of the optical effects of healthy and diseased ocular anterior segment structures on quality of vision

Evaluation of the optical effects of healthy and diseased ocular anterior segment structures on quality of vision - Optical effects of the ocular anterior segment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44740
Enrollment
100
Registered
2017-02-17
Start date
2015-12-22
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diminished quality of vision straylight

Interventions

Patients with dry eyes will undergo the following examinations: 1) documenting subjective complaints of reduced visual quality 2) measurement of best corrected visual acuity 3) straylight measurement
the visual effect will be measured with straylight measurements performed just before the use of coffee creamer and during the 'wash out'-period - with the use of an eyelid speculum the tear break-up
the visual effect of this lengthened tear break-up time will be measured with straylight measurements peformed at regular intervals during the time the eyelid speculum is in situ. - the visual effe
Ocular anterior segment
Optical effects
Quality of vision
Straylight

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: For patients: 1. Subjective straylight complaints, or the presence of an ocular anterior segment disorder which can be the cause of increased straylight. 2. Able to understand the study information and willing to give informed consent.

Exclusion criteria

Exclusion criteria: Ocular posterior segment pathology which can affect the straylight measurements

Design outcomes

Primary

MeasureTime frame
The amount of straylight (mean and range) in patients with anterior segment disorders.

Secondary

MeasureTime frame
Not applicable.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)